Literature DB >> 26231259

N-terminal pro-brain natriuretic peptide and abnormal brain aging: The AGES-Reykjavik Study.

Behnam Sabayan1, Mark A van Buchem1, Anton J M de Craen1, Sigurdur Sigurdsson1, Qian Zhang1, Tamara B Harris1, Vilmundur Gudnason1, Andrew E Arai1, Lenore J Launer2.   

Abstract

OBJECTIVE: To investigate the independent association of serum N-terminal fragment of the prohormone natriuretic peptide (NT-proBNP) with structural and functional features of abnormal brain aging in older individuals.
METHODS: In this cross-sectional study based on the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study, we included 4,029 older community-dwelling individuals (born 1907 to 1935) with a measured serum level of NT-proBNP. Outcomes included parenchymal brain volumes estimated from brain MRI, cognitive function measured by tests of memory, processing speed, and executive functioning, and presence of depressive symptoms measured using the Geriatric Depression Scale. In a substudy, cardiac output of 857 participants was assessed using cardiac MRI.
RESULTS: In multivariate analyses, adjusted for sociodemographic and cardiovascular factors, higher levels of NT-proBNP were independently associated with lower total (p < 0.001), gray matter (p < 0.001), and white matter (p = 0.001) brain volumes. Likewise, in multivariate analyses, higher levels of NT-proBNP were associated with worse scores in memory (p = 0.005), processing speed (p = 0.001), executive functioning (p < 0.001), and more depressive symptoms (p = 0.002). In the substudy, the associations of higher NT-proBNP with lower brain parenchymal volumes, impaired executive function and processing speed, and higher depressive symptoms were independent of the level of cardiac output.
CONCLUSIONS: Higher serum levels of NT-proBNP, independent of cardiovascular risk factors and a measure of cardiac function, are linked with alterations in brain structure and function. Roles of natriuretic peptides in the process of brain aging need to be further elucidated.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26231259      PMCID: PMC4553023          DOI: 10.1212/WNL.0000000000001885

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

Review 1.  Glial cells as sources and targets of natriuretic peptides.

Authors:  Judith Prado; Maria Antonia Baltrons; Paula Pifarré; Agustina García
Journal:  Neurochem Int       Date:  2010-03-17       Impact factor: 3.921

Review 2.  Cardiovascular risk factors, cerebrovascular disease burden, and healthy brain aging.

Authors:  Leon Flicker
Journal:  Clin Geriatr Med       Date:  2010-02       Impact factor: 3.076

Review 3.  Natriuretic peptide testing in heart failure.

Authors:  Han-Na Kim; James L Januzzi
Journal:  Circulation       Date:  2011-05-10       Impact factor: 29.690

4.  Cerebral blood flow in patients with chronic heart failure before and after heart transplantation.

Authors:  N Gruhn; F S Larsen; S Boesgaard; G M Knudsen; S A Mortensen; G Thomsen; J Aldershvile
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

5.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics.

Authors:  Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Olafur Kjartansson; Palmi V Jonsson; Gunnar Sigurdsson; Gudmundur Thorgeirsson; Thor Aspelund; Melissa E Garcia; Mary Frances Cotch; Howard J Hoffman; Vilmundur Gudnason
Journal:  Am J Epidemiol       Date:  2007-03-10       Impact factor: 4.897

6.  Brain magnetic resonance imaging abnormalities in patients with heart failure.

Authors:  Raymond L C Vogels; Wiesje M van der Flier; Barbera van Harten; Alida A Gouw; Philip Scheltens; Jutta M Schroeder-Tanka; Henry C Weinstein
Journal:  Eur J Heart Fail       Date:  2007-08-23       Impact factor: 15.534

7.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

8.  B-type natriuretic peptide and severity of cognitive disorder.

Authors:  Matti Hiltunen; Tuomo Nieminen; Raimo Kettunen; Sirpa Hartikainen; Raimo Sulkava; Olli Vuolteenaho; Tuomas Kerola
Journal:  Eur J Clin Invest       Date:  2013-09-17       Impact factor: 4.686

9.  Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.

Authors:  Razvan T Dadu; Myriam Fornage; Salim S Virani; Vijay Nambi; Ron C Hoogeveen; Eric Boerwinkle; Alvaro Alonso; Rebecca F Gottesman; Thomas H Mosley; Christie M Ballantyne
Journal:  Stroke       Date:  2013-05-09       Impact factor: 7.914

10.  Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.

Authors:  Erik B Schelbert; Jie J Cao; Sigurdur Sigurdsson; Thor Aspelund; Peter Kellman; Anthony H Aletras; Christopher K Dyke; Gudmundur Thorgeirsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Tamara B Harris; Andrew E Arai
Journal:  JAMA       Date:  2012-09-05       Impact factor: 56.272

View more
  6 in total

1.  Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.

Authors:  Lewis H Kuller; Oscar L Lopez; John S Gottdiener; Dalane W Kitzman; James T Becker; Yuefang Chang; Anne B Newman
Journal:  J Am Heart Assoc       Date:  2017-07-22       Impact factor: 5.501

2.  Effects of serum N-terminal pro B-type natriuretic peptide and D-dimer levels on patients with acute ischemic stroke.

Authors:  Jia Li; Chengzhi Gu; Dan Li; Lan Chen; Zhenhui Lu; Lianhai Zhu; Huaiyu Huang
Journal:  Pak J Med Sci       Date:  2018 Jul-Aug       Impact factor: 1.088

3.  Natriuretic Peptides in Post-mortem Brain Tissue and Cerebrospinal Fluid of Non-demented Humans and Alzheimer's Disease Patients.

Authors:  Simin Mahinrad; Marjolein Bulk; Isabelle van der Velpen; Ahmed Mahfouz; Willeke van Roon-Mom; Neal Fedarko; Sevil Yasar; Behnam Sabayan; Diana van Heemst; Louise van der Weerd
Journal:  Front Neurosci       Date:  2018-11-26       Impact factor: 4.677

4.  NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.

Authors:  Takuya Nagata; Tomoyuki Ohara; Jun Hata; Satoko Sakata; Yoshihiko Furuta; Daigo Yoshida; Takanori Honda; Yoichiro Hirakawa; Tomomi Ide; Shigenobu Kanba; Takanari Kitazono; Hiroyuki Tsutsui; Toshiharu Ninomiya
Journal:  J Am Heart Assoc       Date:  2019-08-24       Impact factor: 5.501

5.  N-Terminal pro-Brain Natriuretic Peptide and Associations With Brain Magnetic Resonance Imaging (MRI) Features in Middle Age: The CARDIA Brain MRI Study.

Authors:  Ian T Ferguson; Martine Elbejjani; Behnam Sabayan; David R Jacobs; Osorio Meirelles; Otto A Sanchez; Russell Tracy; Nick Bryan; Lenore J Launer
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

6.  Systemic Inflammation and Cardio-Renal Organ Damage Biomarkers in Middle Age Are Associated With Physical Capability Up to 9 Years Later.

Authors:  Diana Kuh; Rachel Cooper; Naveed Sattar; Paul Welsh; Rebecca Hardy; Yoav Ben-Shlomo
Journal:  Circulation       Date:  2019-04-23       Impact factor: 29.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.